908 Devices MASS
NASDAQ MASS
$10.25 +0.01 (+0.10%)
At close: Aug 20, 2026 · 1:17 PM UTC

908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026)

908 Devices (MASS) posted quarterly Liabilities and Shareholders Equity of $186.7 million for Q1 2026, down 4.76% year-over-year from $196.0 million in Q1 2025, and down 1.78% quarter-over-quarter from $190.1 million in Q4 2025.

908 Devices (MASS) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

908 Devices (MASS) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $186.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 4.76% year-over-year to $186.7 million; the TTM figure through Mar 2026 stood at $759.3 million (up 2.26% YoY), while the FY2025 annual figure was $190.1 million, up 19.18% from the prior year.
  • Liabilities and Shareholders Equity declined to $186.7 million in Q1 2026 per MASS's latest filing, from $190.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $251.2 million in Q1 2022 and bottomed at $159.5 million in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $207.2 million across 5 years, with a median of $203.0 million in 2023.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 49.9% — and 2024, when it retreated 21.43%.
  • 908 Devices' Liabilities and Shareholders Equity stood at $242.6 million in 2022, then slipped by 16.33% to $203.0 million in 2023, then declined by 21.43% to $159.5 million in 2024, then increased by 19.18% to $190.1 million in 2025, then decreased by 1.78% to $186.7 million in 2026.
  • Business Quant data shows MASS's Liabilities and Shareholders Equity at $186.7 million in Q1 2026, $190.1 million in Q4 2025, and $190.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn 109.22 Bn
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 31.04 Bn
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 10.74 Bn
10 908 Devices 386.71 Mn 285.18 Mn 8.34 Mn 197.54 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 197.54 Mn
Mar 31, 2026 186.70 Mn
Dec 31, 2025 190.07 Mn
Sep 30, 2025 190.87 Mn
Jun 30, 2025 191.70 Mn
Mar 31, 2025 196.03 Mn
Dec 31, 2024 159.48 Mn
Sep 30, 2024 178.28 Mn
Jun 30, 2024 208.77 Mn
Mar 31, 2024 189.79 Mn
Dec 31, 2023 202.98 Mn
Sep 30, 2023 208.48 Mn
Jun 30, 2023 210.83 Mn
Mar 31, 2023 218.41 Mn
Dec 31, 2022 242.59 Mn
Sep 30, 2022 249.28 Mn
Jun 30, 2022 247.00 Mn
Mar 31, 2022 251.23 Mn
Dec 31, 2021 260.91 Mn
Sep 30, 2021 166.30 Mn